29-690x361

ADHD Medication: It’s like Giving Meth To Your Children. This Is What You MUST Know

By Anya V via Living Traditionally

Attention deficit hyperactivity disorder is known as a psychiatric disorder that causes attention deficits, hyperactivity, or impulsiveness which is not appropriate for a person’s age. Did you know that ADD and ADHD are not medical conditions? There is no brain scan or blood test to diagnose ADHD. However, doctors can put any child on a deadly schedule I or II pharmaceutical prescription.

According to Dr. Tasneem Bahtia:

“ADD and ADHD are the result of neurotransmitter and neuroendocrine imbalances. The four main imbalances include high norepineprine and cortisol, dopamine dysfunction, serotonin deficiency, and insulin irregularity. Each of these imbalances are rooted in nutritional deficiencies that with correction, improve symptoms of hyperactivity and inattention. Food allergies and intolerances also contribute to malabsorption of nutrients.”

Controversies surrounding ADHD has been around since 1970. The topics of discussions include concerns about its causes, it’s even existence, its suggested treatment, and using stimulant medications as treatment for children and the criteria that is used to diagnosis ADHD. For a diagnosis of ADHD to be made, symptoms must begin by age 6 to 12 years and continue for more than 6 months.

Other concerns are of possible overdiagnosis, misdiagnosis as ADHD leading to undertreatment of other possible psychiatric disorders. According to the American Journal of Psychiatry, there are concerns regarding increased severity of schizophrenia and bipolar disorder, in individuals with a history of stimulant use for ADHD in childhood. Stimulants drugs are not approved for children between the ages of 2 and 6 years. Despite this, between 0.51% to 1.23% of children between theses ages are being treated with stimulants in the USA.

The National Institute of Mental Health states that, “under medical supervision, stimulant medications are considered safe”, and so, they recommend stimulants for the treatment of ADHD. Although, on February 9, 2006, the U.S. Food and Drug Administration recommended a warning label acknowledging the cardiovascular risks of using a stimulant drug to treat ADHD. I find this so appalling because stimulants are classified as Schedule II controlled substances in the United States.

In a recent interview on MSNBC, drug abuse and addiction expert Carl Hart of Columbia University stated that, “There isn’t much difference between the demonized street drug methamphetamine (also known as meth or crystal meth) and the prescription drug Adderall.”
Stimulants for Treatment Of ADHD

Stimulants that are being prescribed include, but not limited to: Ritalin (methylphenidate), and Adderall (a mixture of dextroamphetamine and amphetamine). Treatments with stimulant drugs are very dangerous.

  • According to scientific research funded by the FDA and the National Institute of Mental Health, drugs such as Ritalin increase the risk of sudden death by five hundred percent among children and teens.
  • Ritalin treatment has many side effects: Abdominal Upset, stomach pain, nausea, vomiting, loss of appetite and weight loss. Emotional and Behavioral Side Effects, nervousness, excitability, emotional ups and downs, insomnia and dizziness, headaches, irritability, crankiness, crying, emotional sensitivity, muscle tics or twitches and nervous habits.

Ritalin can be addictive in some patients. Withdrawal from this medication causes several effects: Fatigue, depression, disturbed sleep patterns, malnutrition, and cardiovascular complications which can lead to stroke and even death.

  • Adderall prescription have increased from 1.3 million in 1996 to nearly 6 million in 1999. Adderall is a combination of amphetamine and dextroamphetamine. Amphetamine and dextroamphetamine can be habit-forming.
  • Side effects, including::
    Nervousness, restlessness, difficulty falling asleep or staying asleep, uncontrollable shaking of a part of the body, headache, changes in sex drive or ability, dry mouth, stomach pain, nausea, vomiting, diarrhea, constipation, loss of appetite, weight loss.

NIH recommends anyone who experiences any of these symptoms should call their doctor immediately:

Fast or pounding heartbeat, dhortness of breath, chest pain, excessive tiredness, slow or difficult speech, dizziness or faintness, weakness or numbness of an arm or leg, seizures, motor tics or verbal tics, believing things that are not true, feeling unusually suspicious of others, hallucinating (seeing things or hearing voices that do not exist), mania (frenzied or abnormally excited mood), aggressive or hostile behavior, changes in vision or blurred, vision, fever, blistering or peeling skin, rash, hives, itching, swelling of the eyes, face, tongue, or throat, difficulty breathing or swallowing, and hoarseness.

Thanks for taking the time to read this article. If you found this information helpful, please share it with your friends and family. Your support in our endeavor of sharing free information would be much appreciated.

Sources:
1. Kooij, SJ; Bejerot, S; Blackwell, A; Caci, H; et al. (2010). “European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD”. BMC Psychiatry 10: 67. doi:10.1186/1471-244X-10-67. PMC 2942810. PMID 20815868.
2. Concise Guide to Child and Adolescent Psychiatry (4th illustrated ed.). American Psychiatric Publishing. p. 34. ISBN 9781585624164.
3. “CG72 Attention deficit hyperactivity disorder (ADHD): full guideline” (PDF). UK National Health Service.
4. Ross RG (July 2006). “Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder”. The American Journal of Psychiatry 163 (7): 1149–52. doi:10.1176/appi.ajp.163.7.1149 (inactive 2015-04-14). PMID 16816217.
5. “Statistics on Stimulant Use”. Public Broadcasting Service.
6. Vitiello B (October 2001). “Psychopharmacology for young children: clinical needs and research opportunities”. Pediatrics 108 (4): 983–9. doi:10.1542/peds.108.4.983. PMID 11581454.
7. Jim Rosack. “Controversy Erupts Over Ads for ADHD Drugs”. Psychiatr News 36 (21): 20–21. doi:10.1176/pn.36.21.0020.

share...Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

Comments

comments